Outcomes Following Pre-marking of Episiotomy Location

October 13, 2021 updated by: Sharon Davidesko MD

Short and Long Term Outcomes of Patients With and Without Pre-marked Episiotomy Location

To compare short- and long-term outcomes of women following episiotomy during the second stage of labor, following marking of episiotomy location during the first stage of labor with those of women who underwent episiotomy without marking.

Study Overview

Detailed Description

Purpose: To compare short- and long-term outcomes of women following episiotomy during the second stage of labor, following marking of episiotomy location during the first stage of labor with those of women who underwent episiotomy without marking.

Hypothesis: Women following episiotomy following pre-marking of the location will suffer from fewer short- and long-term complications compared to those without pre-marked episiotomy location.

Study type: prospective randomized-controlled trial

Study Type

Interventional

Enrollment (Anticipated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Be'er Sheva, Israel, 84101
        • Recruiting
        • Soroka University Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women 18 years of age or older who present in active labour to our center and consent to participate in the study

Exclusion Criteria:

  • women under 18 years of age or those who do not or are unable to provide informed consent to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-marked episiotomy location
Women in this group will undergo pre-marking of episiotomy location
A template marking the pre-determined correct location of episiotomy will be used to mark to women in the interventional group
No Intervention: No pre-marked episiotomy location
Women in this group will not undergo pre-marking of episiotomy location

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extended laceration of the episiotomy
Time Frame: Up to 1 hour following the episiotomy
Additional perineal tears originating from the original episiotomy, as described in the birth chart
Up to 1 hour following the episiotomy
Third- and fourth-degree perineal tears
Time Frame: Up to 2 hours following the episiotomy
Perineal tears involving the anal sphincter in addition to the episiotomy, as documented in hospital records
Up to 2 hours following the episiotomy
Post-partum hemorrhage
Time Frame: Up to 6 weeks following delivery
Early (<24 hours) or later (24 hours to 6 weeks) hemorrhage following delivery requiring physician intervention as documented in medical records
Up to 6 weeks following delivery
Blood transfusion requirement
Time Frame: Up to 5 days following delivery
Any requirement for blood products following delivery as documented in the hospital discharge
Up to 5 days following delivery
Episiotomy site infection
Time Frame: Up to 6 weeks following delivery
any documented infection of the episiotomy site treated in ambulatory or hospital setting, as recorded in medical records
Up to 6 weeks following delivery
Requirement of resuturing of episiotomy or evacuation of hematoma
Time Frame: up to 6 weeks following delivery
Any additional surgical intervention required relating to the episiotomy, as recorded in medical records
up to 6 weeks following delivery
Long-term symptoms related to episiotomy
Time Frame: Up to 5 years following delivery
Any symptoms including perineal pain, dyspareunia, urine incontinence or fecal incontinence as reported by women using a numerical scale or dichotomic scale where appropriate
Up to 5 years following delivery
Perineal tears in subsequent deliveries
Time Frame: Up to 5 years following delivery
As recorded in hospital records
Up to 5 years following delivery
Surgical correction of episiotomy
Time Frame: Up to 5 years following delivery
Any additional surgical procedures required for correction of episiotomy related symptoms as recorded in medical records
Up to 5 years following delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sharon Davidesko, MD, Soroka University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 17, 2021

Primary Completion (Anticipated)

September 24, 2025

Study Completion (Anticipated)

September 24, 2025

Study Registration Dates

First Submitted

October 2, 2020

First Submitted That Met QC Criteria

January 20, 2021

First Posted (Actual)

January 22, 2021

Study Record Updates

Last Update Posted (Actual)

October 21, 2021

Last Update Submitted That Met QC Criteria

October 13, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SOR-0089-20-CTIL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No data is to be shared with other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Episiotomy; Complications

Clinical Trials on Pre-marking of episiotomy location

3
Subscribe